Clin2
NCT06699407Possibly a fitNot yet recruiting

Herbal treatment for heart recovery after a heart attack

Chronic Stable Heart Failure

Part of Heart & circulation clinical trials.

This trial tests a Chinese herbal medicine called Qishenyiqi to see if it helps the heart recover and remodel (repair its shape) after a heart attack. It is for people whose heart is still weak (pumping less than 40%) and who have heart failure symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
210 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Had a heart attack more than 3 months ago
  • Heart failure symptoms have been stable for at least 1 month
  • 18 years old or older
  • Heart failure in NYHA class II, III, or IV (mild to severe symptoms)
  • Heart's pumping strength (LVEF) is 40% or less
  • Blood test shows a certain heart stress marker (NT-proBNP) is high (450 or more)
  • No other serious heart, liver, kidney, or cancer conditions that would interfere

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06699420Recruiting· Phase 4
Qishenyiqi pill for small vessel heart disease

This trial tests if a Chinese herbal pill called Qishenyiqi can help people with chest pain caused by tiny heart blood vessels that are too tight. It may be an option if standard tests show your heart vessels are mostly clear but your blood flow is reduced.

Jinan, Shandong
NCT05466968Not yet recruiting· Phase 4
Suxiao Jiuxin pill for stabilizing vulnerable plaques in heart attack

This trial is testing whether a traditional Chinese medicine called Suxiao Jiuxin Pill, when added to standard emergency heart attack treatment (coronary angiography and stenting), can help make the fatty plaques inside your heart arteries more stable and reduce the risk of further heart problems. It's a phase 4 study, meaning the medicine is already used in practice, and this trial aims to gather more evidence on its benefits for people having a heart attack.

Jinan
NCT07687186Recruiting· Phase 3
Qishen Yiqi pills for chronic heart failure

This trial tests whether Qishen Yiqi Dripping Pills, a Chinese herbal medicine, can help people with chronic heart failure caused by coronary heart disease. It is for adults who have been on stable heart failure treatment for at least two weeks.

Bozhou, Anhui
NCT06377761Recruiting
Qishen granules for heart failure with preserved pumping function

This trial tests a Chinese herbal medicine called Qishen Granules for people with heart failure who still have a normal pumping ability (ejection fraction 50% or higher). It may help reduce symptoms and improve heart function.

Guangzhou, Guangdong
NCT05583773Recruiting· Phase 4
Herbal medicine for heart failure with lower pumping strength

This trial tests SHengXIaN-QuYu decoction (an herbal treatment) in people with symptomatic heart failure and reduced pumping function. It looks to see whether the herbal formula is safe and helpful for heart failure symptoms and heart function.

Beijing, Beijing Municipality
NCT07616544Not yet recruiting· Phase 3
Herbal granules after heart stent procedure

This trial tests whether a traditional Chinese herbal medicine called Qidan Xiaoke granules can help people who have had a heart stent placed. It aims to see if the granules improve recovery and reduce future heart problems.

Hear when a new Chronic Stable Heart Failure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.